rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter

NCT00275171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Nodular Goiter

Interventions

DRUG: Recombinant human thyrotropin (Thyrogen)
DRUG: recombinant human TSH
OTHER: isotonic saline = placebo

Sponsor

Steen Bonnema